CINGW
Cingulate Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.01
−0.88%Price chart
Aug 4Aug 7Aug 12Aug 17Aug 21Aug 26Aug 31Sep 4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−0.1x
Market Cap
$60829.51
MomentumView details →
1D Return
−0.88%
YTD Return
−79.34%
RSI (14)
49.3
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−0.1x
Market Cap
$60829.51
RSI (14)
49.3
MomentumView details →
1D Return
−0.88%
YTD Return
−79.34%
Similar companies
Latest newsMore news →
Cingulate Inc. reported its financial results for the second quarter ended June 30, 2026.22d agoCingulate Inc. appointed Zhanpeng "Frederick" Jiang as chairman of the Audit Committee of the Board of Directors, effective July 9, 2026.53d agoCingulate Inc. promoted Shane J. Schaffer to Chief Executive Officer and chairman of the Board of Directors, effective July 9, 2026.53d ago